Money Concepts Capital’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26
Closed -$5.67K 954
2022
Q4
$5.67K Buy
26
+4
+18% +$873 ﹤0.01% 2286
2022
Q3
$4K Hold
22
﹤0.01% 1251
2022
Q2
$5K Sell
22
-4
-15% -$977 ﹤0.01% 1161
2022
Q1
$7K Buy
+26
New +$8.02K ﹤0.01% 2065

Other funds holding CRL

Money Concepts Capital's CRL Position: Q1 2023 in Review

Money Concepts Capital sold out of Charles River Laboratories (CRL) in Q1 2023, closing a stake of 26 shares — an estimated $5.67K sold.

Money Concepts Capital first reported a position in CRL in Q1 2022 and held it in 4 quarters. The position peaked at $7K in Q1 2022. 620 funds tracked by Wall St. Rank hold CRL as of Q1 2023.

  • Money Concepts Capital reported no remaining Charles River Laboratories position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 26 Charles River Laboratories shares in Q1 2023, an estimated $5.67K.
  • Money Concepts Capital first reported a position in Charles River Laboratories in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Charles River Laboratories position peaked at $7K in Q1 2022.
  • 620 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.